在住院环境下非典型的,由特殊咨询服务评估
Jason R Hernandez1, Kyaw Zin Htet2, Jade N Young1
1Oregon Health & Science University School of Medicine, Portland, Oregon, US.
Journal of wound care
|March 11, 2026
概括
患有非典型皮肤的住院患者往往有多种健康问题,死亡风险更高. 这些非糖尿病性,非压力性常常需要多位医疗专家的护理.
科学领域:
- 皮肤病学 皮肤病学
- 血管外科 血管外科
- 传染性疾病 传染性疾病
- 整形外科 整形外科 整形外科
背景情况:
- 住院通常是压力诱导或糖尿病引起的.
- 研究往往忽略了住院患者的非典型病因.
- 非典型的包括炎症性,瘤性,血管性,感染性,药物诱导性或多因素性原因.
研究的目的:
- 在住院环境中对非典型皮肤的患者进行表征.
- 识别非糖尿病性,非压力性,需要专家咨询.
主要方法:
- 住院患者皮肤咨询的回顾性审查.
- 从血管外科,整形外科,传染病和皮肤病数据库中收集的数据.
- 研究期:2015年10月至2020年11月 在俄勒冈健康与科学大学.
主要成果:
- 在322名患者中,包括120名患者.
- 平均年龄为52.46岁,54.2%是女性.
- 最常见的病因:多因素 (30%),传染性 (23.3%),炎症性 (17.5%).
- 95%的人患有并发病;8.3%的人无家可归.
- 18.3%的患者在审查时已死亡.
结论:
- 住院患者的非典型与并发症和死亡率增加有关.
- 这些通常需要复杂的,多专业的护理.
- 需要进行前性研究,以确定患病率和死亡率的易感因素.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
735
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
735
Peptic Ulcer Disease IV: Management
601
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
601
Peptic Ulcer Disease V: Surgical Management and Nursing Care
1.1K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
1.1K
Peptic Ulcer Disease I: Introduction
979
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
979
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.8K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.8K
Peptic Ulcer Disease II: Pathophysiology
2.4K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.4K
